Slenders J P L, Van den Berg-Vos R M, van Heugten C M, Visser-Meily J M A, Evers S M A A, de Haan R J, de Man-van Ginkel J M, Kwa V I H
Department of Neurology, Amsterdam UMC, Amsterdam, the Netherlands.
Department of Neurology, OLVG, Amsterdam, the Netherlands.
BMC Health Serv Res. 2020 Nov 17;20(1):1049. doi: 10.1186/s12913-020-05902-2.
Ischemic stroke patients with a good outcome in terms of motor functioning and communication are likely to be discharged home without further rehabilitation. A significant number of these patients experience cognitive and emotional problems resulting in lower quality of life and decreased participation in society. This paper presents the protocol of a study examining the clinical effectiveness, cost-effectiveness and implementation of an intervention focused on screening and patient-tailored care for cognitive and emotional problems as compared to usual care in patients discharged home after ischemic stroke.
METHODS / DESIGN: A multicenter, patient-blinded, cluster randomized controlled trial will be performed. Centers will be randomized (1:1) to the intervention group or the usual care group. Patients (> 18 years old) with a neurological confirmed diagnosis of ischemic stroke who can be discharged home without follow-up treatment at an outpatient rehabilitation clinic will be included. In the intervention group, patients will receive a short, individualized, semi-structured consultation by specialized nurses in addition to usual care. This consultation includes 1) screening for cognitive and emotional problems, 2) screening for restrictions in participation, 3) promotion of self-management strategies and 4) a decision tool for referral to rehabilitation services. The intervention will be performed approximately 6 weeks after the stroke at the neurology outpatient clinics and will take approximately 60 min. The control group will receive care as usual. Both groups will be followed-up at 6 weeks, 3 months and 12 months after stroke. The primary outcome will be the level of participation measured with the Restriction subscale of the Utrecht Scale for Evaluation of Rehabilitation on the level of Participation (USER-Participation-R) at 12 months. A cost-effectiveness analysis and process evaluation will be performed alongside.
This trial is the first to evaluate clinical effectiveness, cost-effectiveness and implementation of screening and patient-tailored care for cognitive and emotional problems compared to care as usual in patients discharged home after ischemic stroke. Potentially, this will improve the outcomes for patients with frequently occurring cognitive and emotional problems after stroke.
Netherlands Trial Register: NL7295 , registered 25 September 2018.
在运动功能和沟通方面预后良好的缺血性中风患者可能无需进一步康复治疗即可出院回家。这些患者中有相当一部分人存在认知和情感问题,导致生活质量下降和社会参与度降低。本文介绍了一项研究方案,该研究旨在检验一种针对认知和情感问题进行筛查及患者个体化护理的干预措施与缺血性中风出院回家患者的常规护理相比的临床有效性、成本效益及实施情况。
方法/设计:将进行一项多中心、患者盲法、整群随机对照试验。各中心将按1:1随机分为干预组或常规护理组。纳入经神经学确诊为缺血性中风且无需在门诊康复诊所接受后续治疗即可出院回家的患者(年龄>18岁)。在干预组中,患者除接受常规护理外,还将接受专科护士进行的简短、个体化、半结构化咨询。该咨询包括:1)认知和情感问题筛查;2)参与受限筛查;3)自我管理策略推广;4)转介至康复服务的决策工具。干预将在中风后约6周在神经内科门诊进行,耗时约60分钟。对照组将接受常规护理。两组均在中风后6周、3个月和12个月进行随访。主要结局将是在12个月时用乌得勒支康复参与水平评估量表(USER-参与-R)的受限子量表测量的参与水平。同时将进行成本效益分析和过程评估。
本试验是首个评估与缺血性中风出院回家患者的常规护理相比,针对认知和情感问题进行筛查及患者个体化护理的临床有效性、成本效益及实施情况的试验。这可能会改善中风后频繁出现认知和情感问题患者的预后。
荷兰试验注册库:NL7295,于2018年9月25日注册。